The University of Chicago Header Logo

Connection

Randy Sweis to Neoplasm Recurrence, Local

Back to Details
This is a "connection" page, showing publications Randy Sweis has written about Neoplasm Recurrence, Local.
Randy Sweis
Connection Strength
0.036
Neoplasm Recurrence, Local
  1. A phase 1b open-label study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of py314 in combination with pembrolizumab in patients with advanced renal cell carcinoma. Invest New Drugs. 2024 Apr; 42(2):179-184.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.